share_log

Lyra Therapeutics | SC 13G/A: Statement of acquisition of beneficial ownership by individuals (Amendment)-Steven A. Cohen(5.8%),Point72 Asset Management, L.P.(5.7%), etc.

Lyra Therapeutics | SC 13G/A:超过5%持股股东披露文件(修正)-Steven A. Cohen(5.8%),Point72 Asset Management, L.P.(5.7%)等

美股SEC公告 ·  02/15 06:41
声明:本内容仅用作提供资讯及教育之目的,不构成对任何特定投资或投资策略的推荐或认可。 更多信息